This page contains affiliate links. We may earn a commission at no extra cost to you.

$15–$30 for a 60-day supply

Check Price on Amazon
Evidence: Moderate — indirect evidence from deficiency correction, pain physiology research, and some clinical studies in neuropathic pain conditions. Direct RCTs specifically in peripheral neuropathy are limited. Strong rationale for correction of documented deficiency.

Magnesium is the fourth most abundant mineral in the body and a cofactor in over 300 enzymatic reactions, including those governing nerve conduction, neuromuscular transmission, and pain signal modulation. Magnesium deficiency — which is common in diabetic patients, in people taking diuretics or proton pump inhibitors, and in older adults generally — has been associated with increased sensitivity to pain and heightened neuropathic symptoms. Magnesium glycinate (magnesium bound to the amino acid glycine) is one of the most bioavailable and best-tolerated forms of magnesium supplementation, with minimal laxative effect compared to magnesium oxide or citrate. While it is not a primary neuropathy treatment, many patients and practitioners find it a valuable adjunct — particularly for sleep quality and pain sensitivity — when added to a comprehensive neuropathy management plan.

How It Works

Magnesium regulates NMDA (N-methyl-D-aspartate) glutamate receptors — a class of pain receptors that play a central role in central sensitization, the process by which chronic pain becomes amplified and self-perpetuating in the nervous system. Magnesium acts as a physiological NMDA receptor antagonist, blocking these receptors at rest and preventing the calcium influx that drives sensitization. Low magnesium levels effectively remove this protective block, increasing susceptibility to pain amplification. This mechanism is particularly relevant for the central sensitization component of chronic neuropathic pain.

Magnesium also regulates voltage-gated calcium channels in neurons, reducing the release of excitatory neurotransmitters that drive pain signaling. In addition, magnesium is required for ATP production (magnesium-ATP is the active form of cellular energy), normal nerve conduction velocity, and the maintenance of the electrolyte balance across nerve cell membranes. Deficiency in any of these roles can impair nerve function and heighten pain perception. Glycine, the amino acid carrier in magnesium glycinate, also has independent inhibitory neurotransmitter effects that may additionally support sleep and reduce pain sensitivity.

What the Research Says

The evidence for magnesium in peripheral neuropathy is less direct than for ALA or methylcobalamin, but several lines of evidence support its use as an adjunctive supplement. First, magnesium deficiency is disproportionately common in people with diabetes — both because hyperglycemia increases urinary magnesium excretion and because medications such as diuretics and metformin further deplete stores. Correcting deficiency in this population is a reasonable baseline intervention regardless of neuropathy.

Clinical research on IV magnesium for acute neuropathic pain management — particularly CIPN from oxaliplatin — has shown mixed but generally positive results, with some protocols finding that IV magnesium during chemotherapy reduces acute neurotoxicity. Oral magnesium for chronic pain management has been evaluated in conditions including fibromyalgia and migraine, with modest positive results that suggest NMDA receptor modulation is clinically relevant. Direct oral magnesium RCTs specifically in peripheral neuropathy are sparse, which limits the strength of evidence claims.

A 2019 systematic review in Nutrients found associations between low magnesium status and increased pain sensitivity in multiple pain conditions, supporting the rationale for supplementation in pain management broadly.

Why Magnesium Glycinate Is the Preferred Form

Magnesium oxide, the form in most inexpensive supplements, has poor bioavailability (approximately 4 percent absorption) and a strong laxative effect at therapeutic doses. Magnesium glycinate chelates magnesium to glycine, improving absorption to approximately 40 to 80 percent and virtually eliminating the laxative effect that makes other forms difficult to use at full doses. For daily supplementation at meaningful doses, glycinate is the most practical form for most patients.

Magnesium L-threonate is another high-bioavailability form with specific evidence for crossing the blood-brain barrier and increasing brain magnesium levels — potentially relevant for central sensitization in chronic pain. It is more expensive than glycinate. Magnesium malate is another well-tolerated option, particularly for patients with fatigue as a co-symptom. Regardless of form, look for products that specify elemental magnesium content per serving — the milligrams of the compound (e.g., magnesium glycinate) are not the same as elemental magnesium.

Sleep and Magnesium in Neuropathy Patients

Sleep disruption is extremely common in peripheral neuropathy — pain that intensifies at night, restless legs, and autonomic dysregulation all contribute to poor sleep, which in turn amplifies pain perception the following day, creating a vicious cycle. Magnesium glycinate has evidence supporting improved sleep quality independently of its pain effects, through GABA-ergic mechanisms and the calming effect of the glycine carrier. Evening dosing (30 to 60 minutes before bed) of 200 to 400 mg magnesium glycinate is a reasonable approach for neuropathy patients whose sleep is significantly affected.

Better sleep quality does not directly treat neuropathy, but it can meaningfully reduce the subjective intensity of pain and improve daily functioning. This makes addressing sleep a legitimate and important component of comprehensive neuropathy management, and magnesium glycinate represents a low-risk approach to supporting this goal.

Pros

• Corrects magnesium deficiency that is common in diabetic and older neuropathy patients
• Excellent tolerability with no significant laxative effect at therapeutic doses
• May reduce central pain sensitization through NMDA receptor modulation
• Evening dosing may improve sleep quality — addressing a common neuropathy comorbidity
• Very affordable and broadly safe for most adults

Cons

• Limited direct RCTs specifically in peripheral neuropathy — evidence is largely mechanistic and indirect
• Not a primary neuropathy treatment — effects are modest adjunctive
• Patients with kidney disease must use caution — impaired kidneys cannot regulate magnesium excretion
• May interact with bisphosphonate bone medications if taken at the same time

Frequently Asked Questions

How do I know if I’m magnesium deficient?

Serum magnesium testing is available but is an insensitive marker — most body magnesium is intracellular and bone-stored, not in blood. A serum magnesium in the low-normal range may still represent tissue deficiency. Symptoms suggesting low magnesium include muscle cramps, restless legs, poor sleep, and increased pain sensitivity. If you have diabetes, take diuretics or PPIs, or are over 60, empiric supplementation at 200–300 mg daily is reasonable even without testing.

Is it safe to take magnesium if I have kidney disease?

For patients with chronic kidney disease stage 3 or higher (eGFR below 60), magnesium supplementation requires medical supervision. Kidneys regulate magnesium excretion, and impaired kidneys can allow magnesium to accumulate to dangerous levels. Your nephrologist or primary care physician should advise on whether and at what dose supplementation is safe for your level of kidney function.

Can magnesium help with restless legs syndrome associated with neuropathy?

Magnesium deficiency has been associated with restless legs syndrome (RLS), and small studies have found that magnesium supplementation may reduce RLS symptom severity in some patients. For neuropathy patients where RLS overlaps with nocturnal nerve pain, an evening dose of magnesium glycinate is a reasonable and low-risk addition to trial. If RLS symptoms are severe and significantly disrupting sleep, evaluation by your neurologist for RLS-specific treatment is also appropriate.

Buy on Amazon — $15–$30 for a 60-day supply